O. Pedersen (Aarhus, Denmark)
Lung function tests in patients with myasthenia gravis
T. M. Zielonka, A. Kostera-Pruszczyk, B. Ryniewicz, P. Korczynski, B. Szyluk, R. Chazan (Warsaw, Poland)
|  |
Can FEV1% successfully predict respiratory failure/hypercapnea in patients with chronic obstructive pulmonary disease? A prospective study
M. M. Metwally, G. R. Agmy, T. M. Abdel Meguid, S. H. Sadek (Assiut, Egypt)
| |
Functional assessment of respiration before and after hemodialysis in patients with chronic renal failure
H. Dmenska (Warsaw, Poland)
| |
Pulmonary function evaluation in advanced Parkinson‘s disease
J. C. Winck, A. N. Marinho, M. J. Rosas, A. Mendes, P. Linhares, J. Almeida, R. Vaz, J. A. Marques (Porto, Portugal)
| |
Pulmonary function in uremic patients: effects of haemodialysis duration
P. Kovacevic, A. Matavulj, Z. Rajkovaca, N. Ponorac, J. F. Meyer, M. Stanetic (Banja Luka, Bosnia And Herzegovina; Heidelberg, Germany)
| |
Efficacy of telespirometry made "on-line". Preliminary results
I. Utrabo, J. F. Masa, M. T. Gonzalez, J. Corral, R. Pereira, J. J. Gimenez, C. Disdier (Caceres, Spain)
| |
Bronchodilator reversibility testing in COPD: which parameter?
N. Bautin, C. Chenivesse, T. Perez, R. Matran (Lille, France)
| |
FEV1 bronchodilatation response in a population sample and healthy adults
A. Kainu, A. Lindqvist, S. Sarna, A. Sovijärvi (Helsinki, Finland)
| |
The role of FEV6 in bronchodilator reversibility testing of old aged asthmatics
Y. D. Lee, Y. Cho, D. J. Na, M. S. Han (Daejeon, Republic Of Korea)
| |
Use of spirometry software in two major Belgian hospitals
B. Dieriks, M. Behaegel, M. Lins, I. Demedts, E. Derom, D. Coolen (Antwerp, Ghent, Belgium)
| |
Distinguishing hyperinflation from combined restriction in patients with reduced FEV1/FVC and FVC on spirometry
J. B. Eum, Y. M. Oh, S. D. Lee, K. W. Seo, J. J. Ahn, Y. Jegal (Ulsan, Seoul, Republic Of Korea)
| |
Accuracy of spirometry in predicting restrictive pulmonary impairment using different spirometric reference values in Chilean population
M. T. Gutierrez, A. M. Del Fierro, R. A. Vallejo, C. A. Faccilongo (Vina del Mar, Valparaiso, Chile)
| |
The role of FEV1/FEV6 in the detection of airway obstruction
I. Basyigit, H. Boyaci, S. A. Baris, C. I. Yavuz, F. Yildiz (Kocaeli, Turkey)
| |
Role of bronchodilatation in staging severity of patients with COPD
S. Gennimata, A. Chronaiou, E. Kosmas, T. Panomitrou, A. Koutsoukou, N. G. Koulouris (Athens, Greece)
| |
A novel device for the measurement of functional residual capacity (FRC)
M. Gaides, M. Kramer, B. Rechav, J. Smorzik, R. Cohen, R. J. Shiner (Tel Hashomer, Petach Tikva, Jerusalem, Kfar Sava, Herzliya Pituach, Israel)
| |
Mounted or hand held mouth piece assembly influences the measurement of slow vital capacity and its subdivisions
M. L. Storebo, E. Thorsen (Bergen, Norway)
| |
Bronchial hyperreactivity (BHR) in sarcoidosis patients in correlation with airflow limitation indices
M. Martusewicz-Boros, P. Boros, E. Puscinska, S. Wesolowski, D. Gorecka, K. Roszkowski-Sliz (Warsaw, Poland)
| |
Entropy of breathing rate in patients with severe lung diseases
R. H. Zulkarneev, S. Z. Zagidullin, V. E. Bakirova, M. S. Araslanova (Ufa, Russian Federation)
| |
Detection of dynamic airways compression during exercise in COPD by breath-by-breath analysis of spontaneous flow-volume loops
J. Varga, S. Ma, A. Hecht, D. Hsia, R. Casaburi, J. Porszasz (Torrance, United States Of America)
| |